0001127602-22-020417.txt : 20220803 0001127602-22-020417.hdr.sgml : 20220803 20220803174153 ACCESSION NUMBER: 0001127602-22-020417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220801 FILED AS OF DATE: 20220803 DATE AS OF CHANGE: 20220803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salmon Sean CENTRAL INDEX KEY: 0001792380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 221133869 MAIL ADDRESS: STREET 1: MEDTRONIC PLC, 710 MEDTRONIC PARKWAY STREET 2: LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0428 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-08-01 0001613103 Medtronic plc MDT 0001792380 Salmon Sean 710 MEDTRONIC PARKWAY MINNEAPOLIS MN 55432 1 EVP & President Cardiovascular Ordinary Shares 2022-08-01 4 A 0 8595 0 A 36214 D Performance Share Units 2022-08-01 4 A 0 21487 0 A Performance Share Units 21487 21487 D Stock Option (Right to Buy) 93.08 2022-08-01 4 A 0 67924 0 A 2032-08-01 Ordinary Shares 67924 67924 D The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,487 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on August 1, 2025. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. /s/ Thomas L. Osteraas, attorney-in-fact 2022-08-03